Key result
Higher baseline depressive symptoms linked to ~3% lower mortality risk in older Mexican-Americans.
Why the study?
The study aimed to use a joint analysis approach to examine the association between longitudinal depressive symptoms and survival in Mexican Americans.
Are longitudinal depressive symptoms associated with survival in older Mexican Americans?
Cohort (n=3,050)
Yes
Are longitudinal depressive symptoms associated with survival in older Mexican Americans?
Answers are grounded in this paper and cite their sources.
Baseline depressive symptoms, but not their longitudinal trajectory, are significantly associated with mortality in older Mexican Americans.
Objective The primary aim in this study was to use a joint analysis approach to examine the association between longitudinal depressive symptoms and survival in Mexican Americans. Methods: The separate Cox regression and joint modeling were applied to data from the Hispanic Established Population for Epidemiological Study of the Elderly (HEPESE). Depressive symptoms were measured by the Center of Epidemiological Studies Depression Scale (CES-D). The trajectories of CES-D, modeled by random effect, were used as independent variables to fit the mortality curve adjusted by other variables including demographics and physical functioning. Results: The separate Cox regression couldn’t identify association between depressive symptoms and survival. The joint analysis indicated that the slope of CES-D score was not associated with mortality in older Mexican-Americans, however the intercept had negative effects on mortality. Conclusion: There was significant association between baseline depression symptoms and mortality, while no association with slope in older Mexican Americans
No takes yet. Share an insight, caveat, or question.
Yao et al. (2022) conducted a cohort in Depressive symptoms and mortality (n=3,050). Depressive symptoms (CES-D score trajectory) was evaluated on Mortality (HR 0.97, 95% CI 0.95-1.00, p=0.02). In older Mexican-Americans, a higher baseline depressive symptom score was associated with a slightly lower mortality risk, while the longitudinal change in symptoms did not predict mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: